Position in ARGX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,006,284
-$588,998 QoQ
Shares Held
1,378
-27.4% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ARGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026&PARTNERS holds $27,538,864 across 31 Biotechnology names. ARGX ranks #6 (3.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
23,387 | $10,443,230 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
5,404 | $4,175,346 | |
| 3 | INSM |
INSMED Inc
|
8,198 | $1,340,536 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,230 | $1,068,710 | |
| 5 | AXSM |
Axsome Therapeutics, Inc.
|
6,137 | $1,037,275 | |
| 6 | ARGX |
Argenx SE
This page
|
1,378 | $1,006,284 | |
| 7 | ONC |
BeOne Medicines Ltd.
|
2,887 | $857,352 | |
| 8 | IONS |
Ionis Pharmaceuticals Inc
|
10,909 | $819,156 |
All Filings in ARGX
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,006,284 | 1,378 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,595,282 | 1,897 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,073,887 | 1,456 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $764,542 | 1,387 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $912,655 | 1,542 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $717,090 | 1,166 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $408,186 | 753 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $206,419 | 480 | Shares | Sole | 2024-07-24 | |
| No filing history on record for this holder in this stock. | ||||||